Also, the liver and kidney function parameters (TBIL, DBIL, IBIL, ALT, AST, ALB, Scr and BUN)did not significantly change in both CP group and the G group over the 84-day period (Table 1; Figures 1-3, S4, 5).These results suggest that CP can alleviate T2DM-associated clinical markers, blood lipid and blood pressure in addition to alleviating HbA1c in T2DM patients, having no significant impacts on the liver and kidney function. The gene discussed is GPT; the disease is type 2 diabetes mellitus.